A5041626543- Acute Ischemic Stroke Management
- Neurological Disorders and Treatments
- Blood Pressure and Hypertension Studies
- Cerebrovascular and Carotid Artery Diseases
- Stroke Rehabilitation and Recovery
Samara City N.I. Pirogov Clinical Hospital №1
2022-2025
City Clinical Hospital
2022-2025
Thrombolytic therapy (TLT) of ischemic stroke (IS) with alteplase within the first 4.5 hours from onset symptoms is most effective and proven method treatment. Objective: to evaluate safety efficacy TLT Revelisa (alteplase) in IS real-world clinical practice. Material methods. The results were analyzed 1181 patients IS: 616 (52.2%) women 565 (47.8%) men (mean age 68.28±12.56 years), which 140 (11.9%) staged reperfusion. mean time disease was 2.58±0.83 hours. Heidelberg classification used...
Evaluation of the safety and effectiveness thrombolytic therapy (TLT) with drug Revelisa (alteplase) in patients ischemic stroke (AI) real clinical practice.An open prospective multicenter non-interventional register study was conducted, which included 550 AI - 259 (47.1%) women 291 (52.9%) men; average age 67.7±12.6 years. All underwent TLT within 4.5 hours from onset disease and, according to protocol reperfusion AI, clinical, instrumental laboratory examinations were performed....